RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $791M
1-Year Est. Return 12.81%
This Quarter Est. Return
1 Year Est. Return
+12.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$875M
AUM Growth
-$123M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
95
New
Increased
Reduced
Closed

Top Buys

1
+$11.7M
2
+$9.22M
3
+$9.03M
4
UNH icon
UnitedHealth
UNH
+$8.82M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$8.53M

Top Sells

1
+$10.1M
2
+$7.52M
3
+$7.03M
4
EXEL icon
Exelixis
EXEL
+$5.95M
5
LOXO
Loxo Oncology, Inc
LOXO
+$5.6M

Sector Composition

1 Healthcare 93.94%
2 Energy 0.12%
3 Technology 0.11%
4 Financials 0.09%
5 Communication Services 0.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$31.5M 3.6%
126,396
+35,396
2
$30.3M 3.47%
159,691
-15,000
3
$27.3M 3.12%
300,403
+50,529
4
$26.8M 3.06%
408,868
-30,000
5
$25.9M 2.96%
117,875
+35,875
6
$23.6M 2.7%
82,400
+29,400
7
$22.4M 2.56%
230,429
-12,900
8
$21.9M 2.51%
132,425
-10,040
9
$21.2M 2.43%
65,310
+9,609
10
$20.7M 2.36%
78,645
+8,645
11
$20.6M 2.35%
165,818
+39,496
12
$19.2M 2.2%
370,000
+40,000
13
$19.1M 2.19%
264,552
14
$18.9M 2.16%
958,994
-302,420
15
$18.5M 2.11%
946,060
+29,009
16
$18.2M 2.09%
545,000
+145,000
17
$18.1M 2.06%
60,000
+30,000
18
$16.9M 1.94%
266,416
-110,500
19
$16.9M 1.94%
34,333
+13,973
20
$16.3M 1.86%
353,961
21
$16.2M 1.85%
1,203,405
+28,994
22
$15M 1.72%
176,549
-88,300
23
$15M 1.71%
162,415
+32,415
24
$14.5M 1.66%
371,858
+5,471
25
$14.4M 1.64%
201,091
+119,414
1
2 3 4